Influenza Vaccine Randomized Educational Trial: Adult

Not Applicable

Completed

• Conditions: Vaccination; Influenza
• Interventions: Behavioral: Local educational information; Behavioral: National educational information

• Registration Number: NCT02907645
• Lead Sponsor: Columbia University

Brief Summary

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate patients, public health entities and physicians give informational handouts in various forms.

However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. The purpose of this study is to compare the effectiveness of pro-vaccine messages of local data, pro-vaccine messages of national data, and no educational message on patient's receipt of the influenza vaccine. These results will help to understand the relationship between patient education and the intent to vaccinate and receipt of the influenza vaccine as well as to optimize educational information given to patients regarding the influenza vaccine.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-09-08
• Study First Submitted QC: 2016-09-15
• Study First Posted: 2016-09-20
• Study Start: 2016-10-06
• Primary Completion: 2017-05-31
• Study Completion: 2017-06-01
• Status Verified: 2017-07
• Last Update Submitted: 2017-07-26
• Last Update Posted: 2017-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 222

Inclusion Criteria

• visit to study site at time of intervention

Read More

Exclusion Criteria

• prior receipt of influenza vaccine that season

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Local educational	Local educational information	Adult patients in this arm receive educational information regarding influenza vaccination based on local data
National educational	National educational information	Adult patients in this arm receive educational information regarding influenza vaccination based on national data

Primary Outcome Measures

Name	Time	Method
Number of participants who receive influenza vaccination on day of intervention	Day 0	Receipt of influenza vaccination on the day of the educational intervention

Secondary Outcome Measures

Name	Time	Method
Number of participants who receive Influenza vaccination by the end of the influenza vaccine season	Up to 7 months	Receipt of influenza vaccination by April 2017

Trial Locations

Locations (1)

Columbia University Medical Center; 🇺🇸 New York, New York, United States